Influence of bisphosphonates in orthodontic therapy: Systematic review

Journal of Dentistry

Volumn 38, Issue 8, 2010, Pages 603-611

  Iglesias Linares, Alejandro ^a   Yáñez Vico, Rosa María ^a   Solano Reina, Enrique ^a   Torres Lagares, Daniel ^a   González Moles, Miguel Ángel ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Bisphosphonates; Diphosphonates; Mandibular distraction; Maxillary expansion; Orthodontic anchorage; Orthodontics; Relapse; Review; Root resorption; Tooth movement

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ANIMAL; BONE REMODELING; DISTRACTION OSTEOGENESIS; DRUG EFFECT; HUMAN; MANDIBLE RECONSTRUCTION; ORTHODONTICS; PERIODONTAL DISEASE; RECURRENT DISEASE; REVIEW; TOOTH DISEASE; DRUG EFFECTS; ROOT RESORPTION; SECONDARY PREVENTION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DIPHOSPHONATES; HUMANS; MANDIBULAR ADVANCEMENT; ORTHODONTIC ANCHORAGE PROCEDURES; ORTHODONTICS, CORRECTIVE; OSTEOGENESIS, DISTRACTION; PALATAL EXPANSION TECHNIQUE; RECURRENCE; ROOT RESORPTION; TOOTH MOVEMENT; SECONDARY PREVENTION;

EID: 77953706718     PISSN: 03005712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdent.2010.05.012     Document Type: Review

References (44)

1. Rogers M.J., Gordon S., Benford H.L., Coxon F.P., Luckman S.P., Monkkonen J., et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88 (2000) 2961-2978
2. Dunford J.E., Thompson K., Coon F.P., Luckman S.P., Hahn F.M., Poulter C.D., et al. Structure-activity relationships for inhibition of farnesyl diphosphate syntbase in vitro and inhibition of bone resorption in vivo by nitrogen containing bisphosphonates. The Journal of Pharmacology and Experimental Therapeutics 296 (2001) 235-242
3. Frith J.C., Mönkkönen J., Auriola S., Mönkkönen H., and Rogers M.J. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate. Arthritis and Rheumatism 44 (2001) 2201-2210
4. Halasy-Nagy J.M., Rodan G.A., and Reszka A.A. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29 (2001) 553-559
5. Russell R.G., Rogers M.J., Frith J.C., Luckman S.P., Coxon F.P., Benford H.L., et al. The pharmacology of bisphosphonates and new insights into their mechanisms of action. Journal of Bone and Mineral Research 14 Suppl. 2 (1998) 53-65
6. Zahrowski J.J. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach. American Journal of Orthodontics and Dentofacial Orthopedics 131 (2007) 311-320
7. Hortobagyi G.N., Theriaul R.L., Lipton A., Porter L., Blayney D., Sinoff C., et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Journal of Clinical Oncology 16 (1998) 2038-2044
8. Berenson J.R., Lichtenstein A., Porter L., Dimopoulos M.A., Bordoni R., George S., et al. Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Journal of Clinical Oncology 16 (1998) 593-602
9. Glorieux F.H., Bishop N.J., Plotkin H., Chabot G., Lanoue G., and Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. The New England Journal of Medicine 339 (1998) 947-952
10. Bilezikian J.P. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. The American Journal of Medicine 122 (2009) S14-21
11. Wood J., Bonjean K., and Ruetz S. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. The Journal of Pharmacology and Experimental Therapeutics 302 (2002) 1055-1061
12. Fournier P., Boissier S., Filleur S., Guglielmi J., Cabon F., Columbel M., et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Research 62 (2002) 6538-6544
13. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of Oral and Maxillofacial Surgery 62 (2004) 527-534
14. Gonzalez-Moles M.A., and Bagan-Sebastian J.V. Alendronate-related oral mucosa ulcerations. Journal of Oral Pathology & Medicine 29 (2000) 514-518
15. Sarasquete M.E., Gonzalez M., San Miguel J.F., and García-Sanz R. Bisphosphonate-related osteonecrosis: genetic and acquired factors. Oral Diseases 15 (2009) 382-387
16. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83-93
17. Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research 22 (2007) 1479-1491
18. Edwards B.J., Hellstein J.W., Jacobsen P.L., Kaltman S., Mariotti A., and Migliorati C.A. American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw. Updated recommendation for managing the care of patients receiving oral bisphophonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. The Journal of American Dental Association 139 (2008) 1674-1677
19. Zahrowski J.J. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis. American Journal of Orthodontics and Dentofacial Orthopedics 135 (2009) 361-374
20. National Health Service (NHS) Centre for Reviews and Dissemination. Report Number 4. Undertaking Systematic Reviews of Research on Effectiveness. University of York: York Publishing Services; 2001. Available at: www.york.ac.uk/inst/crd/crdrep.htm.
21. Antczak A.A., Tang J., and Chalmers T.C. Quality assessment of randomized control trials in dental research. 1. Methods. Journal of Periodontal Research 1 (1986) 305-314
22. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 17 (1996) 1-12
23. Kimura M., Miyazawa K., Tabuchi M., Maeda H., Kameyama Y., and Goto S. Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin deficient mice. Calcified Tissue International 82 (2008) 137-147
24. Bradaschia-Correa V., Massa L.F., and Arana-Chavez V.E. Effects of alendronate on tooth eruption and molar root formation in young growing rats. Cell and Tissue Research 330 (2007) 475-485
25. Jayawardena C.K., Takahashi N., Watanabae E., and Takano Y. On the origin of intrinsic matrix of acellular extrinsic fiber cementum: studies on growing cementum pearls of normal and bisphosphonate-affected guinea pig molars. European Journal of Oral Sciences 110 (2002) 261-269
26. Arat Z.M., Gökalp H., Atasever T., and Türkkahraman H. 99m Technetium-labeled methylene diphosphonate uptake in maxillary bone during and after rapid maxillary expansion. The Angle Orthodontist 73 (2003) 545-549
27. Nicolay O.F., Khalifa E.R., Lancour M., Hinkle G., and Lanese R. 99mTc-medronate uptake in the temporomandibular joints of young rats treated with a mandibular hyperpropulsor. American Journal of Orthodontics and Dentofacial Orthopedics 100 (1991) 459-464
28. Adachi H., Igarashi K., Mitani H., and Shinoda H. Effects of topical administration of a bisphosphonate (Risedronate) on orthodontic tooth movements in rats. Journal of Dental Research 73 (1994) 1478-1486
29. Igarashi K., Mitani H., Adachi H., and Shinoda H. Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats. American Journal of Orthodontics 106 (1994) 279-289
30. Alatli I., Hellsmg E., and Hammarström L. Orthodontically induced root resorption in rat molars after 1-hydroxyethylidene-1,1-bisphosphonate injection. Acta Odontologica Scandinavica 54 (1996) 102-108
31. Igarashi K., Adachi H., Mitani H., and Shinoda H. Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. Journal of Dental Research 75 (1996) 1644-1649
32. Kim T.W., Yoshida Y., Yokoya K., and Sasaki T. An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. American Journal of Orthodontics and Dentofacial Orthopedics 115 (1999) 645-653
33. Sato Y., Sakai H., Kobayashi Y., Shibasaki Y., and Sasaki T. Bisphosphonate administration alters subcellular localization of vacuolar-type H+-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars. Anatomical Record 260 (2000) 72-80
34. Lee K., Sugiyama H., Imoto S., and Tanne K. Effects of bisphosphonate on the remodeling of rat sagittal suture after rapid expansion. The Angle Orthodontist 7l (2001) 265-273
35. Liu L., Igarashi K., Haruyama N., Saeki S., Shinoda H., and Mitani H. Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats. European Journal of Orthodontics 26 (2004) 469-473
36. Pampu A.A., Dolanmaz D., Tüz H.H., and Karabacakoglu A. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. Journal of Oral and Maxillofacial Surgery 64 (2006) 1232-1236
37. Liu L., Igarashi K., Kanzaki H., Chiba M., Shinoda H., and Mitani H. Clodronate inhibits PGE(2) production in compressed periodontal ligament cells. Journal of Dental Research 85 (2006) 757-760
38. Keles A., Grunes B., DiFuria C., Gagari E., Srinivasan V., Darendeliler M.A., et al. Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force. European Journal of Oral Sciences 115 (2007) 131-136
39. Tekin U., Tüz H.H., Önder E., Özkaynak O., and Korkusuz P. Effects of alendronate on rate on distraction in rabbit mandibles. Journal of Oral and Maxillofacial Surgery 66 (2008) 2042-2049
40. Pampu A.A., Dolanmaz D., Tüz H.H., Avunduk C.M., and Kiscicni R.S. Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits. Journal of Oral and Maxillofacial Surgery 66 (2008) 905-910
41. Goytia R.N., Salama A., and Khanuja H.S. Bisphosphonates and osteonecrosis: potential treatment or serious complication?. Orthopedic Clinics of North America 40 (2009) 223-234
42. Watts N.B. Treatment of osteoporosis with bisphosphonates. Endocrinology Metabolism Clinics of North America 27 (1998) 419-439
43. Van Beek E.R., Lowik C.W., and Papapoulos S.E. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates or osteoclast precursors. Bone 30 (2002) 64-70
44. Alatli I., Li J., and Hammarström L. Ultimate tensile strength of PDL of molars in rats after 1-hydroxyethylidene-1,1-bisphosphonate injections. Journal of Dentistry 25 (1997) 313-319